Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Asthma with IgG Subclass Deficiency
NCT01992328Phase 3Unknown
- Sponsor
- Ajou University School of Medicine
- Start
- Dec 2013
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Human normal immunoglobulin G in asthma, IgG subclass deficiency (IgGSD), sponsored by Ajou University School of Medicine. Status: unknown.
02
Drugs
Human normal immunoglobulin G
03
Conditions
asthmaIgG subclass deficiency (IgGSD)
Beyond the preview
Go deeper on NCT01992328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01992328.